Related references
Note: Only part of the references are listed.Incidence of familial dysautonomia in Israel 1977-1981
Ch. Maayan et al.
CLINICAL GENETICS (2010)
Current evidence for a modulation of nociception by human genetic polymorphisms
Joern Loetsch et al.
PAIN (2007)
Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk
Lian Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer
Polina Voronov et al.
PEDIATRIC ANESTHESIA (2007)
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain:: OPRM1 and COMT gene
Cielito C. Reyes-Gibby et al.
PAIN (2007)
Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both β2- and β3-adrenergic receptors
Andrea Gail Nackley et al.
PAIN (2007)
Genetic Polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans
H-J Park et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations
Y. P. Goldberg et al.
CLINICAL GENETICS (2007)
Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans
Hyungsuk Kim et al.
MOLECULAR PAIN (2007)
The search for migraine genes: an overview of current knowledge
N. J. Colson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Induction of total insensitivity to capsaicin and hypersensitivity to garlic extract in human by decreased expression of TRPV1
Joong Jean Park et al.
NEUROSCIENCE LETTERS (2007)
An SCN9A channelopathy causes congenital inability to experience pain
James J. Cox et al.
NATURE (2006)
Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli
Luda Diatchenko et al.
PAIN (2006)
The human μ-opioid receptor gene polymorphism 118A>G decreases cortical activation in response to specific nociceptive stimulation
Joern Loetsch et al.
BEHAVIORAL NEUROSCIENCE (2006)
Mechanisms of Disease: genetics of fibromyalgia
Jacob N. Ablin et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence
Irmgard Tegeder et al.
NATURE MEDICINE (2006)
Novel mutation in the HSN2 gene in a Korean patient with hereditary sensory and autonomic neuropathy type 2
Hyun-Jung Cho et al.
JOURNAL OF HUMAN GENETICS (2006)
The μ-opioid receptor gene polymorphism 118A > G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carries
Bruno G. Oertel et al.
PHARMACOGENETICS AND GENOMICS (2006)
Genetic predictors for acute experimental cold and heat pain sensitivity in humans
H. Kim et al.
JOURNAL OF MEDICAL GENETICS (2006)
Association of μ-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty
W. -Y. Chou et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2006)
Human opioid receptor A118G polymorphlism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy
Wen-Ying Chou et al.
ANESTHESIOLOGY (2006)
Transcription impairment and cell migration defects in elongator-depleted cells: Implication for familial dysautonomia
Pierre Close et al.
MOLECULAR CELL (2006)
New HSN2 mutation in Japanese patient with hereditary sensory and autonomic neuropathy type 2
M Takagi et al.
NEUROLOGY (2006)
Current evidence for a genetic modulation of the response to analgesics
J Lötsch et al.
PAIN (2006)
Evidence for morphine-independent central nervous opioid effects after administration of codeine: Contribution of other codeine metabolites
J Lotsch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
COMT Val108/158 Met genotype affects the mu-opioid receptor system in the human brain:: Evidence from ligand-binding, G-protein activation and preproenkephalin mRNA expression
A Berthele et al.
NEUROIMAGE (2005)
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk
KA Beaumont et al.
HUMAN MOLECULAR GENETICS (2005)
MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population
MT Landi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients
TT Rakvåg et al.
PAIN (2005)
Melanocortin-1 receptor gene variants affect pain and μ-opioid analgesia in mice and humans
JS Mogil et al.
JOURNAL OF MEDICAL GENETICS (2005)
Two mutations in the HSN2 gene explain the high prevalence of HSAN2 in French Canadians
K Roddier et al.
NEUROLOGY (2005)
Elp1p, the yeast homolog of the FD disease syndrome protein, negatively regulates exocytosis independently of transcriptional elongation
PB Rahl et al.
MOLECULAR CELL (2005)
Polymorphism of μ-opioid receptor gene (OPRM1:c.118A >G) does not protect against opioid-induced respiratory depression despite reduced analgesic response
RR Romberg et al.
ANESTHESIOLOGY (2005)
Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads
EB Liem et al.
ANESTHESIOLOGY (2005)
The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans
RB Fillingim et al.
JOURNAL OF PAIN (2005)
Are μ-opioid receptor polymorphisms important for clinical opioid therapy?
J Lötsch et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Genetic basis for individual variations in pain perception and the development of a chronic pain condition
L Diatchenko et al.
HUMAN MOLECULAR GENETICS (2005)
Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the study of Canadian genetic isolates
RG Lafrenière et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception
E Einarsdottir et al.
HUMAN MOLECULAR GENETICS (2004)
SPTLC1 mutation in twin sisters with hereditary sensory neuropathy type I
K Verhoeven et al.
NEUROLOGY (2004)
Quinidine as a probe for the role of P-glycoprotein in the intestinal absorption and clinical effects of fentanyl
ED Kharasch et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects
S Raimundo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Codeine intoxication associated with ultrarapid CYP2D6 metabolism
Y Gasche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
UM Zanger et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers - Absence of sex differences
R Romberg et al.
ANESTHESIOLOGY (2004)
The 118 A > G polymorphism in the human μ-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
P Klepstad et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2004)
Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament
HS Kim et al.
PAIN (2004)
A mutation in the HSN2 gene causes sensory neuropathy type II in a Lebanese family
JB Rivière et al.
ANNALS OF NEUROLOGY (2004)
GTP-cyclohydrolase I gene mutations in patients with autosomal dominant and recessive GTP-CH1 deficiency: Identification and functional characterization of four novel mutations
B Garavaglia et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2004)
Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication
I Cascorbi
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Identification of the first non-Jewish mutation in familial dysautonomia
M Leyne et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2003)
Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy
T Hirota et al.
DRUG METABOLISM AND DISPOSITION (2003)
The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans
JS Mogil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
COMT val158met genotype affects μ-opioid neurotransmitter responses to a pain stressor
JK Zubieta et al.
SCIENCE (2003)
Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)
M Segawa et al.
ANNALS OF NEUROLOGY (2003)
Simultaneous screening for three mutations in the ABCB1 gene
J Lotsch et al.
GENOMICS (2003)
Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis
K Bejaoui et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Familial dysautonomia:: Detection of the IKBKA-P IVS20+6T→C and R696P mutations and frequencies among Ashkenazi Jews
JL Dong et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Interaction of morphine, fentanyl, sufentanil, affientanil, and loperamide with the efflux drug transporter p-glycoprotein
C Wandel et al.
ANESTHESIOLOGY (2002)
Mutations in the yeast LCB1 and LCB2 genes, including those corresponding to the hereditary sensory neuropathy type I mutations, dominantly inactivate serine palmitoyltransferase
K Gable et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine
J Lotsch et al.
PHARMACOGENETICS (2002)
In-vitro analysis of the contribution of CYP2D6.35 to ultrarapid metabolism
D Allorge et al.
PHARMACOGENETICS (2001)
Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene
H Hahn et al.
ARCHIVES OF NEUROLOGY (2001)
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia
SA Slaugenhaupt et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
SPTLC1 is mutated in hereditary sensory neuropathy, type 1
K Bejaoui et al.
NATURE GENETICS (2001)
Familial dysautonomia is caused by mutations of the IKAP gene
SL Anderson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I
JL Dawkins et al.
NATURE GENETICS (2001)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): Mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor
Y Indo
HUMAN MUTATION (2001)
Affinity, potency and efficacy of tramadol and its metabolites at the cloned human μ-opioid receptor
C Gillen et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
Mutation and polymorphism analysis of the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor in congenital insensitivity to pain with anhidrosis (CIPA) families
Y Miura et al.
HUMAN GENETICS (2000)
Share Paper
